⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5572071 | 0.77 | — | — | |
| SCHEMBL13773387 | 0.74 | CA1 (0.33) | — | |
| SCHEMBL8143416 | 0.70 | LMNA (0.31) | — | |
| SCHEMBL3759349 | 0.70 | CA1 (0.46) | — | |
| SCHEMBL7355622 | 0.69 | ALDH1A1 (0.41) | — | |
| SCHEMBL4177259 | 0.66 | ALDH1A1 (0.54) | — | |
| SCHEMBL41866 | 0.65 | — | — | |
| SCHEMBL54558 | 0.65 | — | — | |
| SCHEMBL22680593 | 0.64 | CA1 (0.39) | — | |
| SCHEMBL2232334 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3743411-B1 | HERBICIDAL 3-PHENYLISOXAZOLIN-5-CARBOXAMIDES OF CYCLOPENTENYL CARBOXYLIC ACID DERIVATIVES | BAYER AG (DE) | 2022-12-21 | — | — | EP | disclosed |
| EP-3770148-A1 | RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | Beijing Tide Pharmaceutical Co., Ltd. (CN) | 2021-01-27 | — | — | EP | disclosed |
| EP-3760620-A1 | RECEPTOR ANTAGONIST, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USAGE THEREOF | Beijing Tide Pharmaceutical Co., Ltd. (CN) | 2021-01-06 | — | — | EP | disclosed |
| WO-2019179515-A1 | RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | 北京泰德制药股份有限公司 | 2019-09-26 | — | — | WO | disclosed |
| EP-2576586-B1 | C-28 AMIDES OF MODIFIED C-3 BETULINIC ACID DERIVATIVES AS HIV MATURATION INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2015-08-12 | — | — | EP | disclosed |
| EP-2305697-A2 | Macrocyclic inhibitors of Hepatitis C virus replication | Intermune, Inc. (US) | 2011-04-06 | — | — | EP | disclosed |
| EP-2305698-A2 | Macrocyclic inhibitors of Hepatitis C virus replication | Intermune, Inc. (US) | 2011-04-06 | — | — | EP | disclosed |
| US-20090207712-A1 | OPTICAL RECORDING MEDIUM AND METHOD OF RECORDING VISIBLE INFORMATION | FUJIFILM CORPORATION (JP) | 2009-08-20 | — | — | US | disclosed |
| EP-2003644-A9 | OPTICAL RECORDING MEDIUM AND VISIBLE INFORMATION RECORDING METHOD | Fujifilm Corporation (JP) | 2009-04-15 | — | — | EP | disclosed |
| US-20090058982-A1 | OPTICAL RECORDING MEDIUM AND METHOD OF RECORDING VISIBLE INFORMATION | FUJIFILM CORPORATION (JP) | 2009-03-05 | — | — | US | disclosed |
| US-7485633-B2 | RNA polymerase, HCV metalloprotease, HCV serine protease, HCV polymerase, HCV helicase inhibitor; liver disease; (+/-)-8-Cyclohexyl-N-4-(morpholinosulfonyl)-1,1a,2,12b-tetrahydro-11-methoxy-1a-(3-methyl-3,8-diazabicyclo[3.2.1]octane-8-carbonyl)cycloprop[d]indolo[2,1-a][2]benzazepine-5-carboxamide | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-02-03 | — | — | US | disclosed |
| US-20090022047-A1 | OPTICAL RECORDING MEDIUM AND METHOD OF RECORDING VISIBLE INFORMATION | FUJIFILM CORPORATION (JP) | 2009-01-22 | — | — | US | disclosed |
| EP-2003644-A2 | OPTICAL RECORDING MEDIUM AND VISIBLE INFORMATION RECORDING METHOD | Fujifilm Corporation (JP) | 2008-12-17 | — | — | EP | disclosed |
| WO-2008112473-A1 | COMPOUNDS FOR THE TREATMENT OF HEPATITIS C | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-09-18 | — | — | WO | disclosed |
| WO-2007014925-A1 | MACROCYLIC INHIBITORS OF HEPATITIS C VIRUS | TIBOTEC PHARMACEUTICALS LTD. (IE) | 2007-02-08 | — | — | WO | disclosed |